Detalles de la búsqueda
1.
Dupilumab in Adults and Adolescents with Eosinophilic Esophagitis.
N Engl J Med;
387(25): 2317-2330, 2022 12 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-36546624
2.
Dupilumab in children aged 6 months to younger than 6 years with uncontrolled atopic dermatitis: a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet;
400(10356): 908-919, 2022 09 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-36116481
3.
Integrated Exposure-Response of Dupilumab in Children, Adolescents, and Adults With Atopic Dermatitis Using Categorical and Continuous Efficacy Assessments: A Population Analysis.
Pharm Res;
40(11): 2653-2666, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-38082089
4.
Drug-Drug Interactions of Glecaprevir and Pibrentasvir Coadministered With Human Immunodeficiency Virus Antiretrovirals.
J Infect Dis;
221(2): 223-231, 2020 01 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31504702
5.
Efficacy and Pharmacokinetics of Glecaprevir and Pibrentasvir With Concurrent Use of Acid-Reducing Agents in Patients With Chronic HCV Infection.
Clin Gastroenterol Hepatol;
17(3): 527-535.e6, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30012435
6.
Translation of In Vitro Transport Inhibition Studies to Clinical Drug-Drug Interactions for Glecaprevir and Pibrentasvir.
J Pharmacol Exp Ther;
370(2): 278-287, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31167814
7.
Pharmacokinetics and safety of glecaprevir and pibrentasvir in HCV-negative subjects with hepatic impairment.
Eur J Clin Pharmacol;
75(2): 217-226, 2019 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-30341499
8.
Efficacy and Safety of Glecaprevir/Pibrentasvir in Patients Coinfected With Hepatitis C Virus and Human Immunodeficiency Virus Type 1: The EXPEDITION-2 Study.
Clin Infect Dis;
67(7): 1010-1017, 2018 09 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-29566246
9.
Effects of Renal Impairment and Hemodialysis on the Pharmacokinetics and Safety of the Glecaprevir and Pibrentasvir Combination in Hepatitis C Virus-Negative Subjects.
Antimicrob Agents Chemother;
62(3)2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29263061
10.
No Clinically Relevant Drug-Drug Interactions between Methadone or Buprenorphine-Naloxone and Antiviral Combination Glecaprevir and Pibrentasvir.
Antimicrob Agents Chemother;
61(10)2017 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28807904
11.
Factor VIII associated with lipidic nanoparticles retains efficacy in the presence of anti-factor VIII antibodies in hemophilia A mice.
Biopharm Drug Dispos;
37(7): 409-420, 2016 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-27418232
12.
Nonlinear pharmacokinetics of factor VIII and its phosphatidylinositol lipidic complex in hemophilia A mice.
Biopharm Drug Dispos;
35(3): 154-63, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24259187
13.
Subcutaneous Administration of Monoclonal Antibodies: Pharmacology, Delivery, Immunogenicity, and Learnings From Applications to Clinical Development.
Clin Pharmacol Ther;
115(3): 422-439, 2024 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38093583
14.
Characterizing complex and competing drug-drug interactions between the antiviral regimen of glecaprevir and pibrentasvir with rifampin or carbamazepine.
Clin Transl Sci;
16(4): 593-605, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36597378
15.
Dupilumab Safety and Efficacy in a Phase III Open-Label Extension Trial in Children 6-11 Years of Age with Severe Atopic Dermatitis.
Dermatol Ther (Heidelb);
13(11): 2697-2719, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37750994
16.
Pharmacokinetics and pharmacodynamics of itepekimab in healthy adults and patients with asthma: Phase I first-in-human and first-in-patient trials.
Clin Transl Sci;
15(2): 384-395, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34523807
17.
Pharmacokinetics of Subcutaneous Dupilumab Injection With an Autoinjector Device or Prefilled Syringe.
Clin Pharmacol Drug Dev;
11(5): 675-681, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35278283
18.
Long-Term Efficacy and Safety of Dupilumab in Adolescents with Moderate-to-Severe Atopic Dermatitis: Results Through Week 52 from a Phase III Open-Label Extension Trial (LIBERTY AD PED-OLE).
Am J Clin Dermatol;
23(3): 365-383, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35567671
19.
The Posology of Dupilumab in Pediatric Patients With Atopic Dermatitis.
Clin Pharmacol Ther;
110(5): 1318-1328, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34270797
20.
Effects of Rovalpituzumab Tesirine on Ventricular Repolarization in Patients With Small-Cell Lung Cancer.
Clin Transl Sci;
14(2): 664-670, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33340277